Advertisement
U.S. Markets closed

Genflow Biosciences plc (GENF.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
1.80000.0000 (0.00%)
At close: 01:24PM GMT
Currency in GBp

Valuation Measures4

Market Cap (intraday) 6.29M
Enterprise Value 5.15M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)7.33
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.56

Trading Information

Stock Price History

Beta (5Y Monthly) 2.36
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.4060
52 Week Low 31.3230
50-Day Moving Average 32.0443
200-Day Moving Average 32.0311

Share Statistics

Avg Vol (3 month) 3604.78k
Avg Vol (10 day) 3317.37k
Shares Outstanding 5349.71M
Implied Shares Outstanding 6N/A
Float 8164.63M
% Held by Insiders 164.24%
% Held by Institutions 19.15%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -256.07%
Operating Margin (ttm)-66.18%

Management Effectiveness

Return on Assets (ttm)-58.66%
Return on Equity (ttm)-118.88%

Income Statement

Revenue (ttm)598.04k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)308.20%
Gross Profit (ttm)N/A
EBITDA -1.53M
Net Income Avi to Common (ttm)-1.53M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.14M
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.73
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-1.01M
Levered Free Cash Flow (ttm)-461.18k